Etoposide: four decades of development of a topoisomerase II inhibitor
- 1 September 1998
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10), 1514-1521
- https://doi.org/10.1016/s0959-8049(98)00228-7
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Antitopoisomerase drug action and resistanceEuropean Journal Of Cancer, 1996
- The Importance of Drug Scheduling in Cancer Chemotherapy: Etoposide as an ExampleThe International Journal of Cell Cloning, 1996
- Topoisomerase InhibitorsDrugs, 1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- Randomized Trial of Doxorubicin, Bisantrene, and Miltoxantrone in Advanced Breast Cancer: A Southwest Oncology Group StudyJNCI Journal of the National Cancer Institute, 1991
- MitoxantroneDrugs, 1991
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cellsBiochemistry, 1976
- Interaction between DNA and an Escherichia coli protein ωJournal of Molecular Biology, 1971
- The Similarity of the Effect of Podophyllin and Colchicine and Their Use in the Treatment of Condylomata AcuminataScience, 1946